| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1329 | 2018 |
| Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ... Jama 321 (1), 69-79, 2019 | 1072 | 2019 |
| A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial N Kobyliak, L Abenavoli, G Mykhalchyshyn, L Kononenko, L Boccuto, ... | 206 | 2018 |
| Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, D Kyriienko, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12 (5), 617-624, 2018 | 177 | 2018 |
| Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA DK McGuire, JH Alexander, OE Johansen, V Perkovic, J Rosenstock, ... Circulation 139 (3), 351-361, 2019 | 165 | 2019 |
| Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a … J Rosenstock, V Perkovic, JH Alexander, ME Cooper, N Marx, MJ Pencina, ... Cardiovascular diabetology 17, 1-15, 2018 | 87 | 2018 |
| Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study N Kobyliak, L Abenavoli, T Falalyeyeva, G Mykhalchyshyn, L Boccuto, ... | 87 | 2018 |
| Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial GJ Biessels, C Verhagen, J Janssen, E van den Berg, B Zinman, ... Diabetes care 42 (10), 1930-1938, 2019 | 66 | 2019 |
| Ендокринологія ПН Боднар, ЮІ Комісаренко, ГП Михальчишин, МІ Бобрик, ... Нова Книга, 2020 | 65 | 2020 |
| Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: secondary analysis of the CARMELINA randomized trial V Perkovic, R Toto, ME Cooper, JFE Mann, J Rosenstock, DK McGuire, ... Diabetes care 43 (8), 1803-1812, 2020 | 57 | 2020 |
| Markers of adiposity among children and adolescents: implications of the isotemporal substitution paradigm with sedentary behavior and physical activity patterns PD Loprinzi, BJ Cardinal, H Lee, C Tudor-Locke Journal of Diabetes & Metabolic Disorders 14, 1-14, 2015 | 57 | 2015 |
| Эндокринология ПН Боднар, ГП Михальчишин, ЮИ Комиссаренко, АМ Приступюк, ... Нова Книга, 2016 | 56 | 2016 |
| Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients G Mykhalchyshyn, N Kobyliak, P Bodnar Journal of Diabetes & Metabolic Disorders 14, 1-7, 2015 | 55 | 2015 |
| Неалкогольна жирова хвороба печінки у хворих на цукровий діабет типу 2: патогенез, діагностика та лікування PM Bodnar Endokrynologia 17 (1), 94-101, 2012 | 51 | 2012 |
| Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A … N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, N Molochek, O Savchuk, ... Obesity Medicine 19, 100248, 2020 | 38 | 2020 |
| Comparative experimental investigation on the efficacy of mono-and multiprobiotic strains in non-alcoholic fatty liver disease prevention N Kobyliak, T Falalyeyeva, O Virchenko, G Mykhalchyshyn, P Bodnar, ... BMC gastroenterology 16, 1-9, 2016 | 36 | 2016 |
| Probiotics and smectite absorbent gel formulation reduce liver stiffness, transaminase and cytokine levels in NAFLD associated with type 2 diabetes: a randomized clinical study N Kobyliak, L Abenavoli, G Mykhalchyshyn, T Falalyeyeva, O Tsyryuk, ... Clinical Diabetology 8 (4), 205-214, 2019 | 24 | 2019 |
| Metabolic profile and morpho-functional state of the liver in rats with glutamate-induced obesity M Kondro, G Mykhalchyshyn, P Bodnar, N Kobyliak, T Falalyeyeva Curr Issues Pharm Med Sci 26 (4), 379-381, 2013 | 23 | 2013 |
| Йододефіцитні захворювання та їх профілактика ПМ Боднар, ГП Михальчишин Міжнародний ендокринологічний журнал, 6, 2006 | 18 | 2006 |
| Актуальні питання діагностики та лікування цукрового діабету ПМ Боднар, ГП Михальчишин Мистецтво лікування 1 (1), 51-55, 2003 | 17 | 2003 |
Tetyana Falalyeyeva, Тетяна Фалалє...Professor, Taras Shevchenko National University of KyivПідтверджена електронна адреса в knu.ua
